Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Ted Bosworth

    News

    Topical anticholinergic for axillary hyperhidrosis shows fewer side effects

    Author:
    Ted Bosworth
    Publish date: April 25, 2021

    The agent, which shows strong activity at the application site but reduced systemic activity, is moving through the U.S. regulatory process.

    • Read More

    News

    Systematic approach to pain helps avoid opioid issues for dermatologists

    Author:
    Ted Bosworth
    Publish date: April 24, 2021

    For most skin diseases, dermatologists should take the lead for pain management, but there are exceptions.

    • Read More

    News

    In low-risk thyroid cancer, no advantage found for postsurgical iodine

    Author:
    Ted Bosworth
    Publish date: April 5, 2021

    Forgoing postoperative radioactive iodine in low-risk differentiated thyroid cancer is supported by phase 3 data.

    • Read More

    News

    Denosumab now dominant therapy for osteoporosis linked to cancer

    Author:
    Ted Bosworth
    Publish date: March 25, 2021

    In changing patterns of osteoporosis drug prescriptions, denosumab has risen to the top of cancer indications.

    • Read More

    News

    Obesity pegged as source of marked increased risk of diabetes in PCOS

    Author:
    Ted Bosworth
    Publish date: March 25, 2021

    Obesity has been identified as the key risk factor for type 2 diabetes in women with polycystic ovary syndrome in a new study. It suggests that...

    • Read More

    News

    PCOS equivalent in men: No ovaries required

    Author:
    Ted Bosworth
    Publish date: March 24, 2021

    High polygenic risk score establishes a genetic polycystic ovary syndrome–like syndrome identifiable in men as...

    • Read More

    News

    Success in achondroplasia spurs testing vosoritide in more growth disorders

    Author:
    Ted Bosworth
    Publish date: March 21, 2021

    The quality of growth achieved with vosoritide in achondroplasia is leading to studies in more growth disorders.

    • Read More

    News

    Colchicine before PCI for acute MI fails to improve major outcomes

    Author:
    Ted Bosworth
    Publish date: March 17, 2021

    In STEMI patients scheduled for PCI, preprocedural colchicine fails to improve outcomes in the randomized...

    • Read More

    News

    Target-lesion failure reduced 2 years after MI with biodegradable stent

    Author:
    Ted Bosworth
    Publish date: March 15, 2021

    Two-year results from the BIOSTEMI trial shows advantage for biodegradable polymer stent in the setting of myocardial infarction.

    • Read More

    News

    BASILICA technique prevents TAVR-related coronary obstruction in registry study

    Author:
    Ted Bosworth
    Publish date: March 11, 2021

    The largest ongoing BASILICA registry supports this procedure for TAVR-associated coronary obstruction.

    • Read More

    News

    DOACs offered after heart valve surgery despite absence of data

    Author:
    Ted Bosworth
    Publish date: March 9, 2021

    Use of direct oral anticoagulants following heart valve surgery is occurring despite relative contraindications, but expert doubts its clinical...

    • Read More

    News

    Cumulative exposure to high-potency topical steroid doses drives osteoporosis fractures

    Author:
    Ted Bosworth
    Publish date: February 16, 2021

    "A 3% increase in the relative risk of osteoporosis and MOF was observed per doubling of the TCS dose."

    • Read More

    News

    Women and ACS: Focus on typical symptoms to improve outcomes

    Author:
    Ted Bosworth
    Publish date: February 11, 2021

    Strict guideline adherence could reverse the poorer acute coronary syndrome outcomes in women. Chest pain “is pretty much equal between men and...

    • Read More

    News

    In head-to-head trial, two biologics differ markedly for control of psoriasis

    Author:
    Ted Bosworth
    Publish date: February 4, 2021

    For psoriasis, a novel IL-17A/-17F inhibitor was more effective than the IL-12/-23 inhibitor ustekinumab.

    • Read More

    News

    Newer iPhones disable implanted defibrillators

    Author:
    Ted Bosworth
    Publish date: February 1, 2021

    Some newer smartphones are equipped with magnets sufficiently powerful to disable an implanted cardiac defibrillator.

    • Read More

    Pages

    • « first
    • …
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery